Adaptive Biotechnologies Corporation

NasdaqGS:ADPT Stock Report

Market Cap: US$3.4b

Adaptive Biotechnologies Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:ADPT Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
18 May 26SellUS$40,620Kyle PiskelIndividual3,115US$13.04
11 Mar 26SellUS$214,131Michelle GriffinIndividual15,394US$13.91
11 Mar 26SellUS$831,067Sharon BenzenoIndividual63,103US$13.17
11 Mar 26SellUS$544,421Susan BobulskyIndividual41,338US$13.17
11 Mar 26SellUS$1,613,628Julie RubinsteinIndividual122,523US$13.17
11 Mar 26SellUS$6,193,403Harlan RobinsIndividual470,266US$13.17
11 Mar 26SellUS$245,910Kyle PiskelIndividual18,672US$13.17
11 Mar 26SellUS$6,192,099Chad RobinsIndividual470,167US$13.17
05 Mar 26SellUS$574,537Francis LoIndividual38,074US$15.09
10 Dec 25SellUS$367,488Robert HershbergIndividual22,968US$16.00
17 Nov 25SellUS$3,344Kyle PiskelIndividual238US$14.05

Insider Trading Volume

Insider Buying: ADPT insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of ADPT?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders4,449,4242.72%
Hedge Funds29,993,70818.3%
Institutions129,399,16679%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 70.99% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
18.7%
Viking Global Investors LP
29,993,708US$631.7m0%1.57%
8.31%
BlackRock, Inc.
13,303,025US$280.2m-0.23%no data
4.27%
Sumitomo Mitsui Trust Asset Management Co., Ltd.
6,833,137US$143.9m0%0.07%
3.81%
Vanguard Capital Management, LLC
6,094,144US$128.3m0%no data
3.4%
Westfield Capital Management Company, L.P.
5,436,718US$114.5m33.9%0.41%
2.81%
Vanguard Portfolio Management, LLC
4,491,474US$94.6m0%no data
2.7%
Invesco Ltd.
4,317,371US$90.9m46.4%0.02%
2.41%
Wellington Management Group LLP
3,857,422US$81.2m78.2%0.01%
2.27%
Geode Capital Management, LLC
3,636,054US$76.6m3.54%no data
2.21%
Lord, Abbett & Co. LLC
3,536,103US$74.5m14.8%0.2%
2.02%
State Street Global Advisors, Inc.
3,227,245US$68.0m1.43%no data
1.89%
Columbia Management Investment Advisers, LLC
3,017,341US$63.5m16.5%0.01%
1.68%
BNPP Asset Management Holding
2,688,081US$56.6m38%0.06%
1.55%
T. Rowe Price Group, Inc.
2,485,491US$52.3m-43.4%no data
1.51%
Goldman Sachs Asset Management, L.P.
2,418,729US$50.9m20.8%0.01%
1.31%
ARK Investment Management LLC
2,092,969US$44.1m-2.15%0.26%
1.29%
Fred Alger Management, LLC
2,063,146US$43.4m-8.12%0.14%
1.25%
Arrowstreet Capital, Limited Partnership
1,995,202US$42.0m-17.6%0.02%
1.23%
D. E. Shaw & Co., L.P.
1,965,610US$41.4m3.31%0.03%
1.18%
Nomura Investment Management Business Trust
1,881,183US$39.6m-3.05%0.05%
1.09%
Driehaus Capital Management LLC
1,750,601US$36.9m-36.6%0.16%
1.07%
Aristotle Atlantic Partners, LLC
1,714,346US$36.1m-6.95%1.01%
1.07%
Principal Global Investors, LLC
1,704,887US$35.9m9.81%0.01%
1%
Amova Asset Management Co., Ltd.
1,595,370US$33.6m-18.1%0.01%
0.95%
Chad Robins
1,520,498US$32.0m-7.35%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/12 01:58
End of Day Share Price 2026/07/10 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Adaptive Biotechnologies Corporation is covered by 13 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Derik de BruinBofA Global Research
Mark MassaroBTIG
William BonelloCraig-Hallum Capital Group LLC